Literature DB >> 7893873

Epidemiology of infection due to Chlamydia trachomatis in Manitoba, Canada.

P Orr1, E Sherman, J Blanchard, M Fast, G Hammond, R Brunham.   

Abstract

In a study of the epidemiology of Chlamydia trachomatis infection in Manitoba during 1981-1990, we retrospectively reviewed laboratory and clinical case notification records as well as hospital and health insurance data concerning pelvic inflammatory disease and ectopic pregnancy. After implementation of a control program in 1987, the annual incidence of chlamydial infection was highest among females aged 15-24 years (3,418 cases per 100,000 residents). Recurrent infection, which occurred in 13.4% of patients, was more common in women (P < .001), patients aged 15-24 years (P < .001), registered North American Indians (P < .001), and persons with concomitant gonorrhea (P < .001). Risk factors for dual (chlamydial and gonococcal) infection included male sex (P < .001) and young age (P < .001). Although the incidence of hospitalization and outpatient visits for pelvic inflammatory disease decreased (P < .001) from 1981 to 1990, the annual incidence of ectopic pregnancy increased from 10 to 16 cases per 1,000 reported pregnancies (P < .001). Control activities focusing on the primary prevention of C. trachomatis infection are presented. Strategies for improving secondary prevention (through case detection and treatment of lower genital infection) include the targeting of individuals with recurrent and multiple sexually transmitted diseases.

Entities:  

Mesh:

Year:  1994        PMID: 7893873     DOI: 10.1093/clinids/19.5.876

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  7 in total

1.  No room to assume in birth control.

Authors:  A Katz
Journal:  Can Fam Physician       Date:  1996-02       Impact factor: 3.275

2.  Incidence and reinfection rates of genital chlamydial infection among women aged 16-24 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the Chlamydia Recall Study Advisory Group.

Authors:  D Scott Lamontagne; Kathleen Baster; Lynsey Emmett; Tom Nichols; Sarah Randall; Louise McLean; Paula Meredith; Veerakathy Harindra; Jean M Tobin; Gillian S Underhill; W Graham Hewitt; Jennifer Hopwood; Toni Gleave; Ajit K Ghosh; Harry Mallinson; Alisha R Davies; Gwenda Hughes; Kevin A Fenton
Journal:  Sex Transm Infect       Date:  2006-10-18       Impact factor: 3.519

3.  Sociodemography of genital Chlamydia trachomatis in Coventry, UK, 1992-6.

Authors:  A J Winter; P Sriskandabalan; A A Wade; C Cummins; P Barker
Journal:  Sex Transm Infect       Date:  2000-04       Impact factor: 3.519

4.  Treatment of Chlamydia trachomatis infections in pregnant women.

Authors:  J M Miller; D H Martin
Journal:  Drugs       Date:  2000-09       Impact factor: 9.546

5.  Risk factors for genital chlamydial infection.

Authors:  Christine Navarro; Anne Jolly; Rama Nair; Yue Chen
Journal:  Can J Infect Dis       Date:  2002-05

6.  The evolving epidemiology of chlamydial and gonococcal infections in response to control programs in Winnipeg, Canada.

Authors:  J F Blanchard; S Moses; C Greenaway; P Orr; G W Hammond; R C Brunham
Journal:  Am J Public Health       Date:  1998-10       Impact factor: 9.308

7.  Laboratory Detection of First and Repeat Chlamydia Cases Influenced by Testing Patterns: A Population-Based Study.

Authors:  Laura H Thompson; Zoann Nugent; John L Wylie; Carla Loeppky; Paul Van Caeseele; James F Blanchard; Nancy Yu
Journal:  Microbiol Insights       Date:  2019-02-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.